Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Social determinants of health in lung cancer surgery: perspectives from family caregivers, clinicians, and healthcare system administrators.

Frontiers in public health·2026
Same author

Interrelationship Between Patient and Family Caregiver Outcomes Following Lung Cancer Surgery: A Secondary Analysis of a Randomized Controlled Trial.

Psycho-oncology·2026
Same author

Squamous Non-Small Cell Lung Cancer: Current and Emerging Treatment Options.

Clinical lung cancer·2025
Same author

Survival and Treatment Patterns in Stage II to III Esophageal Cancer.

JAMA network open·2024
Same author

Geriatric Assessment-driven INterventions among Hospitalized older adults with cancer (GAIN-HOSP), a prospective pilot study.

Journal of geriatric oncology·2024
Same author

Comparative effectiveness of perioperative physical activity in older adults with lung cancer and their family caregivers: design of a multicenter pragmatic randomized trial.

BMC cancer·2024

相关实验视频

Updated: Jul 6, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

可切除非小细胞肺癌的快速进展:叙述性综述

Howard Jack West1,2, Jae Y Kim3

  • 1Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.

JAMA oncology
|December 28, 2023
PubMed
概括

对可切除非小细胞肺癌 (NSCLC) 的新疗法可以改善存活率. 辅助性 osimertinib 和新辅助性化学免疫疗法正在改变护理标准,但最佳的患者选择和治疗顺序需要进一步研究.

科学领域:

  • 在瘤学瘤学.
  • 胸部外科手术 胸部外科手术
  • 基因组医学是基因组医学.

背景情况:

  • 最近的临床试验显著改变了可切除早期非小细胞肺癌 (NSCLC) 的护理标准.
  • 新的辅助疗法和新辅助疗法显示出更好的疗效,这引发了关于临床应用的问题.
  • 不断变化的环境需要重新评估NSCLC的治疗策略.

研究的目的:

  • 审查最近在可切除早期NSCLC治疗方面的进展.
  • 讨论新的治疗选择对临床实践和患者管理的影响.

主要方法:

  • 对可切除早期NSCLC的知名临床试验的分析.
  • 对辅助性奥西默蒂尼布,尼沃卢马布化疗和辅助性阿特佐利祖马布/佩布罗利祖马布的数据的审查.

主要成果:

  • 辅助性 osimertinib 显著改善了 EGFR 突变的 NSCLC 中的 DFS 和 OS.
  • 使用尼沃卢马布的新辅助化疗改善了无事件生存率 (EFS).
  • 辅助剂阿特佐利祖马布在PD-L1高NSCLC中显示OS益处;潘布罗利祖马布显示DFS益处.

结论:

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

相关实验视频

Last Updated: Jul 6, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
  • 新的辅助和新辅助疗法代表了可切除NSCLC治疗的重大进展.
  • 由于数据不断变化,临床判断和患者讨论对于导航治疗选择至关重要.
  • 需要进一步的研究来优化对这些新型NSCLC疗法的测序和患者选择.